SIOX - Sio Gene Therapies GAAP EPS of -$0.05 February, 14 2023 07:39 AM Sio Gene Therapies Inc. Sio Gene Therapies press release ( NASDAQ: SIOX ): Q3 GAAP EPS of -$0.05. As of December 31, 2022, we had $46.13 million of cash and cash equivalents. For further details see: Sio Gene Therapies GAAP EPS of -$0.05